Atlas Trials

Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases

Clinical trial NCT01337440 · UNKNOWN

Trial details

NCT number
NCT01337440
Sponsor
Kanazawa University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusChronic Liver Disease
Start date
2010-04-01
Primary completion
2013-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.